Categories: HealthcareNews

Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference

CHARLESTOWN, Mass. , April 13, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and Chief Executive Officer, will present at the 22nd Annual Needham Healthcare Conference on Thursday, April 20, 2023 at 8:00 AM ET.

Mr. Cumbo will also participate in a gene therapy panel discussion on Thursday, April 20, 2023 at 11:45 AM ET.

A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here. A replay will be available on the Company’s website following the event. The panel discussion will be made available live only to clients of Needham.

Institutional investors interested in meeting with management during the conference may reach out to their Needham representative.

About Solid Biosciences

Solid Biosciences is a life science company focused on advancing a portfolio of neuromuscular and cardiac programs, including SGT-003, a differentiated gene transfer candidate for the treatment of Duchenne, AVB-202-TT, a gene transfer candidate for the treatment of Friedreich’s Ataxia, AVB-401 for BAG3 mediated dilated cardiomyopathy, and additional assets for the treatment of undisclosed cardiac diseases. Solid aims to be the center of excellence, bringing together those with expertise in science, technology, disease management and care. Patient-focused and founded by those directly impacted by Duchenne, Solid’s mandate is to improve the daily lives of patients living with these devastating diseases. For more information, please visit www.solidbio.com.

Solid Biosciences Investor Contact:
David Carey
FINN Partners
212-867-1768
David.Carey@finnpartners.com

Solid Biosciences Media Contact:
Tim Palmer
Associate Director, Corporate Communications
607-760-4223
Tim@solidbio.com

Staff

Recent Posts

Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks

CHENGDU, China, July 16, 2024 /PRNewswire/ -- "Evolving DNA-Encoded Library Technology and Its Application for Innovative…

2 hours ago

AI Tool Successfully Responds to Patient Questions in Electronic Health Record

NEW YORK, July 16, 2024 /PRNewswire/ -- As part of a nationwide trend, many more…

2 hours ago

TeleSpecialists Revolutionizes Stroke Care with Launch of Innovative EMS Integration Service

EMS Integration to enhance door-to-needle times and elevate patient outcomes FORT MYERS, Fla., July 16,…

2 hours ago

XO Health Powers Provider Search and Improved Transparency with Kyruus Health

BOSTON, July 16, 2024 /PRNewswire/ -- XO Health, an innovative health care services organization designed…

2 hours ago

Radiation Detection, Monitoring, and Safety Market: $4.4 Billion by 2029, CAGR 8.3% | MarketsandMarkets™

CHICAGO, July 16, 2024 /PRNewswire/ -- The global radiation detection, monitoring, and safety market, valued…

2 hours ago

GHX Survey Reveals Healthcare Executives’ Top Four Expectations for the Next Decade

Artificial Intelligence, Integrated Health Systems and Government Policies Will Shape the Industry's Trajectory and Transformation…

2 hours ago